8 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
., where she led all aspects of commercial strategy, operations and performance. Prior to joining SOBI, Ms. May held leadership roles of increasing
6-K
EX-99
BLRX
Bioline Rx Ltd
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am
and performance. Prior to joining SOBI, Ms. May held leadership roles of increasing strategic importance across marketing, operations, sales, and planning
6-K
EX-99
8m6de 0u9pisfp7eg
19 Aug 13
BioLineRx Appoints B. J. Bormann to
12:00am
20FR12B
EX-4.17
nj1c7zj6yukqlxgj
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.17
061im5n
24 Sep 10
Registration statement (foreign)
12:00am
- Prev
- 1
- Next